ORGANOGENESIS INC.

Company Snapshot

Founded: 1985

Entity Type: Public

Employees: 869

Region: U.S.

Revenue: $482.0 Millions

Revenue Year: 2024

Headquarter: Massachusetts, U.S.

Key Geographics: U.S.

Corporate Address: 85 Dan Road, Canton, Massachusetts 02021 U.S. Tel. +1-781-575-0775 www.organogenesis.com

Company Overview

Organogenesis Inc. is a company specializing in regenerative medicine and tissue innovation, commercializing products for the advanced wound care, surgical, and sports medicine markets. Advanced wound care offers a portfolio of regenerative products, including Apligraf, Dermagraft, PuraPly AM, CYGNUS Dual, and multiple placental allografts for treating chronic and acute wounds. Surgical and sports medicine products such as NuShield, PuraForce, and PuraPly variants support soft tissue repair and surgical wound healing. It also has a product pipeline targeting advanced wound care, as well as surgical and sports medicine. Some include line extensions for PuraPly, which feature antimicrobial collagen scaffolds, as well as smaller-size versions of Apligraf and Dermagraft to enhance the treatment of chronic wounds. The pipeline also includes expanding placental-derived products through internal research and development (R&D) and external partnerships.

Financial Highlights (FY 2024)

Net Revenue: ***

Total Current Liabilities: ***

Total Current Assets: ***

R&D expenses: ***

Operating Income: ***

This information is available for BCC Research members only.

Already a Member? Sign In Become a Member